Combinatorial drug treatment for cancer
The aim of the project is to integrate computational, experimental and analytical approaches to predict the effect of anti-cancer drugs. This approach will provide knowledge about combinations of drugs and how to tailor the treatment to the individual patient. Research and development is focused on patients with colorectal cancer.
Innovation: DrugLogics develops technology and knowledge in close collaboration with industrial partners, and the goal is to improve clinical cancer treatment.
The project is funded by NTNU Health.